Here, we demonstrate that HNF4A expression during murine pancreatic cancer development in the KPC (Pdx1-Cre; LSL-KrasG12D; Trp53R172H) genetically engineered mouse model progressively declines from the early stages of the disease from PanIN lesions to PDAC. The gene discussed is HNF4A; the disease is pancreatic neoplasm.